Biologic medicines require precise, user-friendly self-injection devices for repeat dosing.
R&D Focus
High-precision pen injectors for biologics
Innovative Solution
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1.
Investment Funding
Last Funding Stage
Series A
Last Funding Date
09-09-2024
Startup Stage
Early Stage
Lead Investors
Lightspeed China Partners, Maotai Jianxin (Guizhou) Investment Fund, Jiayuan Capital, Yinman Venture Capital
About
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1.
Products
Product
High-precision reusable and disposable pen injectors for insulin, growth hormone and GLP-1 medicines.
Demo Product or Complete Product?
Complete product – commercially available.
Something missing or incorrect on this page? Help us enrich this information
